A role for fulvestrant monotherapy in the first-line treatment of ER plus metastatic breast cancer?

被引：2
|
作者：
Mahtani, Reshma L. [1 ]
机构：
[1] Univ Miami Hlth Syst, Div Hematol Oncol, Sylvester Comprehens Canc Ctr, 1192 East Newport Ctr Dr, Deerfield Beach, FL 33442 USA
来源：
BREAST JOURNAL | 2020年 / 26卷 / 02期
关键词：
POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; ANASTROZOLE; ABEMACICLIB; THERAPY; COMBINATION; PALBOCICLIB;
D O I：
10.1111/tbj.13495
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109 / 111
页数：3
相关论文
共 50 条
  • [21] Current problems in the first-line treatment of metastatic breast cancer: focus on the role of docetaxel
    Montemurro, Filippo
    CLINICAL MANAGEMENT ISSUES, 2010, 4 (03) : 97 - 107
  • [22] Role of cetuximab in first-line treatment of metastatic colorectal cancer
    Miguel Jhonatan Sotelo
    Beatriz García-Paredes
    Carlos Aguado
    Javier Sastre
    Eduardo Díaz-Rubio
    World Journal of Gastroenterology, 2014, (15) : 4208 - 4219
  • [23] Role of cetuximab in first-line treatment of metastatic colorectal cancer
    Sotelo, Miguel Jhonatan
    Garcia-Paredes, Beatriz
    Aguado, Carlos
    Sastre, Javier
    Diaz-Rubio, Eduardo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (15) : 4208 - 4219
  • [24] Real-World Efficacy of Fulvestrant Monotherapy as the First Treatment or Maintenance Treatment in Patients with Metastatic Breast Cancer
    Lv, Meng
    Mao, Yan
    Ma, Teng
    Wang, Yongmei
    Liu, Xiaoyi
    Song, Yuhua
    Wang, Haibo
    BREAST CARE, 2021, 16 (04) : 368 - 375
  • [25] First-Line Capecitabine Monotherapy for Slowly Progressing Metastatic Breast Cancer: Do We Need Aggressive Treatment?
    Debled, Marc
    Madranges, Nicolas
    Trainaud, Alexandra
    Floquet, Anne
    Donamaria, Catherine
    Brouste, Veronique
    Durand, Michel
    Mauriac, Louis
    ONCOLOGY, 2009, 77 (05) : 318 - 327
  • [26] Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER-2 negative breast cancer.
    Altundag, Kadri
    Babacan, Taner
    Efe, Orhan
    Hasirci, Ahmet S.
    Demirci, Fatih
    Buyukhatipoglu, Hakan
    Balakan, Ozan
    Sarici, Furkan Saim
    Kertmen, Neyran
    Esin, Ece
    Akin, Serkan
    Ates, Ozturk
    Aksoy, Sercan
    Sever, Ali R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] Real-world effectiveness of fulvestrant monotherapy as first endocrine treatment in patients with metastatic breast cancer
    Skinner, Karen E.
    Olufade, Temitope
    Walker, Mark S.
    Schwartzberg, Lee S.
    BREAST JOURNAL, 2020, 26 (02): : 112 - 119
  • [28] First-Line Chemotherapy for Metastatic Breast Cancer
    Telli, Melinda L.
    Carlson, Robert W.
    CLINICAL BREAST CANCER, 2009, 9 : S66 - S72
  • [29] A COMPARISON OF FIRST-LINE TREATMENT WITH GEMCITABINE PLUS DOCETAXEL VERSUS GEMCITABINE PLUS VINORELBINE IN WOMEN WITH METASTATIC BREAST CANCER
    Bensalem, A.
    Bouzid, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [30] Half-dose fulvestrant plus anastrozole as a first-line treatment for hormone receptor-positive metastatic breast cancer: a cost-effectiveness analysis
    Huang, Xiaoting
    Weng, Xiuhua
    Lin, Shen
    Liu, Yiwei
    Luo, Shaohong
    Wang, Hang
    Ming, Wai-kit
    Huang, Pinfang
    BMJ OPEN, 2020, 10 (08):
12345